- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The daily dosage of Ibrutinib should be adjusted according to the indications, age, and liver function status. It is usually taken orally once ...
Ibrutinib is a targeted therapy drug mainly used to treat various B-cell malignancies and chronic graft-versus-host disease. Its indications in...
Epclusa, as a treatment drug for hepatitis C virus (HCV), the duration of its course of treatment needs to be personalized according to the pat...
Epclusa is a compound formulation composed of sofosbuvir and velpatasvir, specifically designed for the treatment of chronic hepatitis C virus ...
Dasatinib, as a tyrosine kinase inhibitor, has contraindications mainly related to specific disease states, drug interactions, and special popu...
Epclusa is a compound formulation composed of Sofosbuvir and Velpatasvir. It is the world's first oral antiviral drug for the full genotype hep...
The recommended medication time for Epclusa is fixed daily and can be taken on an empty stomach or after a meal, but attention should be paid t...
Axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), mainly used for second-line treatment of advanc...
Axitinib is an oral small molecule tyrosine kinase inhibitor primarily used as second-line therapy for advanced renal cell carcinoma, blocking ...
Axitinib is a VEGFR tyrosine kinase inhibitor mainly used for second-line treatment of advanced renal cell carcinoma. Its target population nee...
